JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 13, 2026

Total Value: $652M (100.0% shares, 0.0% debt)

Holdings (16)

PTGX Protagonist Therapeutics Inc. 39.6%

Value $258M Shares 2,449,183 Est. Cost $42.63 Unrealized +95.3%

NBTX Nanobiotix S.A. 26.6%

Value $174M Shares 5,623,816 Est. Cost $7.53 Unrealized —

MGTX MeiraGTx Holdings plc 8.8%

Value $57.51M Shares 6,641,064 Est. Cost $9.84 Unrealized -22.6%

RAPP Rapport Therapeutics, Inc. 8.6%

Value $55.84M Shares 1,784,517 Est. Cost $23.15 Unrealized +20.2%

CVRX CVRx, Inc. 5.8%

Value $38.08M Shares 4,024,861 Est. Cost $19.85 Unrealized -66.4%

CTNM Contineum Therapeutics Inc. 4.0%

Value $25.85M Shares 1,979,173 Est. Cost $16.10 Unrealized -17.1%

LEGN Legend Biotech Corporation 2.3%

Value $14.74M Shares 814,586 Est. Cost $50.56 Unrealized —

XNCR Xencor, Inc. 1.4%

Value $9.022M Shares 748,062 Est. Cost $37.91 Unrealized -66.6%

PRCT Procept BioRobotics Corporation 1.4%

Value $8.952M Shares 357,939 Est. Cost $38.38 Unrealized -22.9%

FATE Fate Therapeutics, Inc. 0.6%

Value $4.055M Shares 3,379,064 Est. Cost $78.44 Unrealized -98.5%

NMRA Neumora Therapeutics, Inc. 0.6%

Value $3.606M Shares 1,849,445 Est. Cost $12.57 Unrealized -80.4%

RLYB Rallybio Corporation 0.2%

Value $1.372M Shares 152,901 Est. Cost $5.22 Unrealized 0.0%

VOR Vor Biopharma, Inc. 0.1%

Value $959K Shares 53,732 Est. Cost $18.62 Unrealized -24.9%

LAB Standard BioTools, Inc. 0.0%

Value $287K Shares 311,967 Est. Cost $2.41 Unrealized -44.1%

NNOX Nano-X Imaging Ltd. 0.0%

Value $190K Shares 83,554 Est. Cost $15.61 Unrealized -82.6%

ACET Adicet Bio, Inc. 0.0%

Value $155K Shares 22,779 Est. Cost $11.05 Unrealized -29.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PTGX	Protagonist Therapeutics Inc.	2,449,183	$258M	39.6%	$42.63	+95.3%	COM	74366E102
NBTX	Nanobiotix S.A.	5,623,816	$174M	26.6%	$7.53	—	SPONSORED ADS	63009J107
MGTX	MeiraGTx Holdings plc	6,641,064	$57.51M	8.8%	$9.84	-22.6%	COM	G59665102
RAPP	Rapport Therapeutics, Inc.	1,784,517	$55.84M	8.6%	$23.15	+20.2%	COM	75383L102
CVRX	CVRx, Inc.	4,024,861	$38.08M	5.8%	$19.85	-66.4%	COM	126638105
CTNM	Contineum Therapeutics Inc.	1,979,173	$25.85M	4.0%	$16.10	-17.1%	CL A	21217B100
LEGN	Legend Biotech Corporation	814,586	$14.74M	2.3%	$50.56	—	SPONSORED ADS	52490G102
XNCR	Xencor, Inc.	748,062	$9.022M	1.4%	$37.91	-66.6%	COM	98401F105
PRCT	Procept BioRobotics Corporation	357,939	$8.952M	1.4%	$38.38	-22.9%	COM	74276L105
FATE	Fate Therapeutics, Inc.	3,379,064	$4.055M	0.6%	$78.44	-98.5%	COM	31189P102
NMRA	Neumora Therapeutics, Inc.	1,849,445	$3.606M	0.6%	$12.57	-80.4%	COM	640979100
RLYB	Rallybio Corporation	152,901	$1.372M	0.2%	$5.22	0.0%	COM	75120L209
VOR	Vor Biopharma, Inc.	53,732	$959K	0.1%	$18.62	-24.9%	COM NEW	929033207
LAB	Standard BioTools, Inc.	311,967	$287K	0.0%	$2.41	-44.1%	COM	34385P108
NNOX	Nano-X Imaging Ltd.	83,554	$190K	0.0%	$15.61	-82.6%	ORD SHS	M70700105
ACET	Adicet Bio, Inc.	22,779	$155K	0.0%	$11.05	-29.8%	COM NEW	007002207